AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12534557 — intervention group
Group type: EXPERIMENTAL
Intervention: Air cleaners in the living room and bedroom for 12 months and using high efficiency particulate air filter vacuum cleaners
Number of subjects: 30
Study 12534557 — intervention group
Group type: COMPARATOR
Intervention: Using high efficiency particulate air filter vacuum cleaners alone
Number of subjects: 30
Study 9706322 — intervention group
Group type: EXPERIMENTAL
Intervention: Schematic maps
Number of subjects: 95
Study 9706322 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer feedback
Number of subjects: 95
Study 9706322 — intervention group
Group type: COMPARATOR
Intervention: Essay group (control)
Number of subjects: 95
Study 7753750 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (Prilosec)
Number of subjects: 0
Study 7753750 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 0
Study 7753750 — intervention group
Group type: COMPARATOR
Intervention: Long-term medical therapy
Number of subjects: 0
Study 7753750 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study 2225558 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium infusion at 15 ml/hour using 10% CaCl2
Number of subjects: 6
Study 2225558 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium infusion at 20 ml/hour using 10% CaCl2
Number of subjects: 6
Study 2225558 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium infusion at 10 ml/hour using 10% CaCl2
Number of subjects: 6
Study 2225558 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialyzate with 1.5 mmol/l calcium
Number of subjects: 6
Study 2225558 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialyzate with 1.75 mmol/l calcium
Number of subjects: 6
Study 2225558 — intervention group
Group type: COMPARATOR
Intervention: Dialyzate calcium-free with varying calcium infusion rates
Number of subjects: 6
Study 487912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g per day for 4 weeks)
Number of subjects: 51
Study 487912 — intervention group
Group type: COMPARATOR
Intervention: Antacid (210 ml/day for 4 weeks)
Number of subjects: 51
Study 31375051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasotraline 4 mg
Number of subjects: 112
Study 31375051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 31256084 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-motor exergame training (CMT)
Number of subjects: 24
Study 31256084 — intervention group
Group type: COMPARATOR
Intervention: Conventional training (CT)
Number of subjects: 24
Study 27417142 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased sleep duration (1.5 hours/night for 1 week)
Number of subjects: 37
Study 27417142 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased sleep duration (1.5 hours/night for 1 week)
Number of subjects: 37
Study 25762165 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 20 mg/day for 1 week, then 40 mg/day for 3 weeks
Number of subjects: 34
Study 25762165 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B12 (VB12) 1.5 mg/day for 4 weeks
Number of subjects: 34
Study 24145488 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous pool technique (VPT) for blood sampling
Number of subjects: 74
Study 24145488 — intervention group
Group type: COMPARATOR
Intervention: Needlestick technique
Number of subjects: 74
Study 21469249 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-current reflexotherapy
Number of subjects: 84
Study 21469249 — intervention group
Group type: COMPARATOR
Intervention: Medicamental therapy (Control)
Number of subjects: 84
Study 19396541 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-vision rehabilitation using MP-1 biofeedback examination (10 weeks, 10 training sessions of 10 min each, once a week)
Number of subjects: 5
Study 16309929 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic education and functional readaptation (TEFR) added to conventional (pharmacological) treatment (n=51)
Number of subjects: 100
Study 16309929 — intervention group
Group type: COMPARATOR
Intervention: Conventional (pharmacological) treatment only (n=49)
Number of subjects: 100
Study 15270367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 28
Study 15270367 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip Dynamometry (HGD)
Number of subjects: 28
Study 15270367 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthostatic Tolerance Test (OTT)
Number of subjects: 28
Study 15270367 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery Phase after CPT and HGD
Number of subjects: 28
Study 15270367 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva Maneuver (VM)
Number of subjects: 28
Study 15270367 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Breathing Test for sinus arrhythmia (SA)
Number of subjects: 28
Study 11301848 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and cisplatin as induction therapy followed by concomitant chemoradiation
Number of subjects: 187
Study 11301848 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based combinations (with gemcitabine, paclitaxel, or vinorelbine) as induction therapy
Number of subjects: 187
Study 9224195 — intervention group
Group type: EXPERIMENTAL
Intervention: Car seat distribution with education on car restraint use
Number of subjects: 0
Study 9224195 — intervention group
Group type: COMPARATOR
Intervention: Car seat distribution without education
Number of subjects: 0
Study 8424584 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose polyunsaturated fatty acids from fish oil (350 mg daily) in microencapsulated form
Number of subjects: 12
Study 8424584 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose polyunsaturated fatty acids from fish oil (350 mg daily) in gelatine capsules
Number of subjects: 12
Study 8424584 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations of fish oil
Number of subjects: 12
Study 29701067 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥65 years age group
Number of subjects: 1211
Study 29701067 — intervention group
Group type: COMPARATOR
Intervention: Younger age group
Number of subjects: 1211
Study 29701067 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-chest symptom clusters
Number of subjects: 1211
Study 29701067 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical and typical symptom clusters in ≥65 years group
Number of subjects: 1211
Study 27444039 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine oral solution 50 mg
Number of subjects: 42
Study 27444039 — intervention group
Group type: COMPARATOR
Intervention: Atomoxetine capsules 50 mg
Number of subjects: 42
Study 27444039 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine oral solution
Number of subjects: 42
Study 24840583 — intervention group
Group type: EXPERIMENTAL
Intervention: Taped condition during walking
Number of subjects: 15
Study 24840583 — intervention group
Group type: EXPERIMENTAL
Intervention: Taped condition during jogging
Number of subjects: 15
Study 24840583 — intervention group
Group type: COMPARATOR
Intervention: Untaped condition
Number of subjects: 15
Study 22104298 — intervention group
Group type: EXPERIMENTAL
Intervention: Calisthenics exercises for 6 months
Number of subjects: 107
Study 22104298 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises for 6 months
Number of subjects: 107
Study 22104298 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific training)
Number of subjects: 107
Study 21102973 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic only (Group I)
Number of subjects: 40
Study 21102973 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic mixed with non-particulate betamethasone (Group II)
Number of subjects: 40
Study 18523316 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in lipid profile (average LDL decreased by 28%, average HDL increased by 8%)
Number of subjects: 1315
Study 18523316 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CAD regression (n = 756)
Number of subjects: 1315
Study 18523316 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in lipid profile
Number of subjects: 1315
Study 16150136 — intervention group
Group type: EXPERIMENTAL
Intervention: phe-free protein substitute supplemented with EFA (test-treatment group)
Number of subjects: 43
Study 16150136 — intervention group
Group type: COMPARATOR
Intervention: phe-free, fat-free protein substitute (control group)
Number of subjects: 43
Study 12849766 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with HD
Number of subjects: 60
Study 12849766 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene-carriers of HD
Number of subjects: 60
Study 12849766 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 60
Study 10388983 — intervention group
Group type: EXPERIMENTAL
Intervention: Macroalbuminuric subjects (AER = 300 mg/day)
Number of subjects: 1160
Study 10388983 — intervention group
Group type: EXPERIMENTAL
Intervention: Entire group
Number of subjects: 1160
Study 10388983 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoalbuminuric DCCT group
Number of subjects: 1160
Study 8637536 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (800 mg of sulfamethoxazole and 160 mg of trimethoprim) given twice daily for 24 months
Number of subjects: 81
Study 8637536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 8637536 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 81
Study 1642821 — intervention group
Group type: EXPERIMENTAL
Intervention: Single inclinometry
Number of subjects: 8
Study 1642821 — intervention group
Group type: EXPERIMENTAL
Intervention: Double inclinometry
Number of subjects: 8
Study 1642821 — intervention group
Group type: EXPERIMENTAL
Intervention: Back range-of-motion inclinometry
Number of subjects: 8
Study 1642821 — intervention group
Group type: COMPARATOR
Intervention: B-200
Number of subjects: 8
Study 6472539 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (3 g/day)
Number of subjects: 10
Study 6472539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31829921 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Date Palm Kernel Extract (DPKE) cream applied twice daily for 8 weeks
Number of subjects: 43
Study 31829921 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 43
Study 30596725 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternity waiting homes (MWHs)
Number of subjects: 2381
Study 26418444 — intervention group
Group type: COMPARATOR
Intervention: C2F6 gas endotamponade (Group A)
Number of subjects: 21
Study 26418444 — intervention group
Group type: EXPERIMENTAL
Intervention: Densiron 68 tamponade (Group B)
Number of subjects: 21
Study 25147029 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 500
Study 22766770 — intervention group
Group type: EXPERIMENTAL
Intervention: Souvenaid
Number of subjects: 0
Study 22766770 — intervention group
Group type: COMPARATOR
Intervention: Iso-caloric control product
Number of subjects: 0
Study 19577859 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months short-term neoadjuvant androgen deprivation (STAD) before and during prostatic irradiation (XRT)
Number of subjects: 802
Study 19577859 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months short-term neoadjuvant androgen deprivation (STAD) before and during prostatic irradiation (XRT)
Number of subjects: 802
Study 19577859 — intervention group
Group type: COMPARATOR
Intervention: XRT alone
Number of subjects: 802
Study 19577859 — intervention group
Group type: EXPERIMENTAL
Intervention: TTBF measured from end of radiation (ERT)
Number of subjects: 802
Study 19577859 — intervention group
Group type: EXPERIMENTAL
Intervention: TTBF measured from testosterone recovery
Number of subjects: 802
Study 18187428 — intervention group
Group type: EXPERIMENTAL
Intervention: PGA (60 mg)
Number of subjects: 24
Study 18187428 — intervention group
Group type: COMPARATOR
Intervention: Control (without PGA)
Number of subjects: 24
Study 15890731 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist (cetrorelix 0.25 mg daily starting when the leading follicle reached 14 mm)
Number of subjects: 87
Study 15890731 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist protocol
Number of subjects: 87
Study 12626212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) using a combination of transdermal estradiol gel and a progestin other than MPA
Number of subjects: 3175
Study 9509074 — intervention group
Group type: COMPARATOR
Intervention: Loose diet (Group B)
Number of subjects: 42
Study 9509074 — intervention group
Group type: COMPARATOR
Intervention: Strict diet (Group A)
Number of subjects: 42
Study 9509074 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 42
Study 8208872 — intervention group
Group type: EXPERIMENTAL
Intervention: Galanthamine 10 mg
Number of subjects: 18
Study 8208872 — intervention group
Group type: EXPERIMENTAL
Intervention: Galanthamine 15 mg
Number of subjects: 18
Study 8208872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2563217 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin pretreatment
Number of subjects: 10
Study 2563217 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 10
Study 2563217 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral potassium pretreatment
Number of subjects: 10
Study 1164890 — intervention group
Group type: EXPERIMENTAL
Intervention: Sisomicin (1.0 mg/kg body-weight, 2-3 times daily)
Number of subjects: 36
Study 1164890 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (1.0 mg/kg body-weight, 1-hour infusion)
Number of subjects: 36
Study 1164890 — intervention group
Group type: COMPARATOR
Intervention: Sisomicin (1.0 mg/kg body-weight, 1-hour infusion)
Number of subjects: 36
Study 1164890 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin (1.0 mg/kg body-weight, 1-hour infusion)
Number of subjects: 36
Study 1164890 — intervention group
Group type: EXPERIMENTAL
Intervention: Sisomicin
Number of subjects: 36
Study 30616534 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib titration (5 mg bid)
Number of subjects: 112
Study 28253404 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology (ortho-k) lenses
Number of subjects: 136
Study 28253404 — intervention group
Group type: COMPARATOR
Intervention: Control (single-vision spectacles)
Number of subjects: 136
Study 25431484 — intervention group
Group type: EXPERIMENTAL
Intervention: CDAI
Number of subjects: 102
Study 25431484 — intervention group
Group type: EXPERIMENTAL
Intervention: SDAI
Number of subjects: 102
Study 23651793 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 × 30 mg/mL subcutaneous injection
Number of subjects: 14
Study 23651793 — intervention group
Group type: COMPARATOR
Intervention: 2 × 15 mg/mL subcutaneous injections
Number of subjects: 14
Study 21060995 — intervention group
Group type: EXPERIMENTAL
Intervention: BZP/TFMPP (100/30 mg)
Number of subjects: 36
Study 21060995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 19548931 — intervention group
Group type: EXPERIMENTAL
Intervention: Charge-Coupled Device (CCD) system
Number of subjects: 206
Study 19548931 — intervention group
Group type: COMPARATOR
Intervention: Photostimulable Phosphor (PSP) system
Number of subjects: 206
Study 17308499 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg soy-derived isoflavones
Number of subjects: 191
Study 17308499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study 15183623 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression treatment with superficial venous surgery
Number of subjects: 500
Study 15183623 — intervention group
Group type: COMPARATOR
Intervention: Compression treatment alone
Number of subjects: 500
Study 11546660 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenergic blockade (prazosin hydrochloride and timolol malate)
Number of subjects: 6
Study 11546660 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 6
Study 11546660 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenergic blockade (prazosin hydrochloride and timolol malate) during exercise
Number of subjects: 6
Study 11546660 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 6
Study 9514434 — intervention group
Group type: EXPERIMENTAL
Intervention: Postanal repair
Number of subjects: 20
Study 9514434 — intervention group
Group type: COMPARATOR
Intervention: Total pelvic floor repair
Number of subjects: 20
Study 7527916 — intervention group
Group type: EXPERIMENTAL
Intervention: DRE + TRUS
Number of subjects: 2
Study 7527916 — intervention group
Group type: COMPARATOR
Intervention: PSA
Number of subjects: 2
Study 2500848 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous, microbial beta-D-galactosidase (lactase)
Number of subjects: 12
Study 2500848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 820708 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of synthetic TRH three times a day, 30 minutes before breast feeding
Number of subjects: 16
Study 820708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31358616 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle biopsy reading by experts
Number of subjects: 24
Study 31358616 — intervention group
Group type: EXPERIMENTAL
Intervention: Holistic muscle biopsy interpretation
Number of subjects: 24
Study 29446785 — intervention group
Group type: EXPERIMENTAL
Intervention: Salso-bromo-iodine thermal water solution administered by nasal douche twice/day for 10 days a month for 3 months
Number of subjects: 80
Study 29446785 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline administered by nasal douche twice/day for 10 days a month for 3 months
Number of subjects: 80
Study 27291502 — intervention group
Group type: EXPERIMENTAL
Intervention: Papilla base incision (PBI)
Number of subjects: 24
Study 27291502 — intervention group
Group type: COMPARATOR
Intervention: Sulcular incision (IS)
Number of subjects: 24
Study 25231186 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg)
Number of subjects: 16
Study 25231186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22369223 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing negative pictures
Number of subjects: 70
Study 22369223 — intervention group
Group type: COMPARATOR
Intervention: Viewing positive pictures
Number of subjects: 70
Study 22369223 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait restriction
Number of subjects: 70
Study 22369223 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait temptation
Number of subjects: 70
Study 22369223 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affect
Number of subjects: 70
Study 20815272 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutuo Qingfu Decoction (GQD) via gastro-enteric perfusion
Number of subjects: 60
Study 20815272 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 60
Study 17413915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment blockade (FICB) with 1.0% mepivacaine
Number of subjects: 48
Study 17413915 — intervention group
Group type: COMPARATOR
Intervention: Placebo FICB with 0.9% saline and intramuscular injection of 0.1 mg/kg morphine
Number of subjects: 48
Study 16237512 — intervention group
Group type: EXPERIMENTAL
Intervention: Group education session (2 hours) supplemented by brief individualized session (10 minutes)
Number of subjects: 359
Study 16237512 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instruction)
Number of subjects: 359
Study 11849633 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive patch (Ortho Evra/Evra)
Number of subjects: 1785
Study 11849633 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive
Number of subjects: 1785
Study 10492057 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg) administered during the ovulatory phase (days 13-16 post-onset of menses)
Number of subjects: 10
Study 10492057 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg) administered during the luteal phase (days 22-26 post-onset of menses)
Number of subjects: 10
Study 10492057 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg) administered during the follicular phase (days 2-6 post-onset of menses)
Number of subjects: 10
Study 8724047 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention emphasizing HIV transmission and condom use
Number of subjects: 2160
Study 8724047 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2160
Study 8724047 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 2160
Study 2206774 — intervention group
Group type: EXPERIMENTAL
Intervention: OK-432 (5 KE orally for 7-14 days)
Number of subjects: 14
Study 2206774 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study 7034755 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg orally
Number of subjects: 9
Study 7034755 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo not specified)
Number of subjects: 9
Study 30616653 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized context-based SDM face-to-face training (IG I)
Number of subjects: 162
Study 30616653 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based interactive SDM online training (IG II)
Number of subjects: 162
Study 30616653 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) receiving no SDM training
Number of subjects: 162
Study 28035542 — intervention group
Group type: EXPERIMENTAL
Intervention: CZSG (12 mg orally, thrice daily)
Number of subjects: 120
Study 28035542 — intervention group
Group type: COMPARATOR
Intervention: KFX (10 mL orally, thrice daily)
Number of subjects: 120
Study 25261418 — intervention group
Group type: COMPARATOR
Intervention: Standard dose (400/100 mg)
Number of subjects: 154
Study 25261418 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose (600/150 mg)
Number of subjects: 154
Study 25049340 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention targeting both child and parent, including diet and activity education over 12 months (13 sessions) followed by 12-month follow-up (3 sessions).
Number of subjects: 105
Study 25049340 — intervention group
Group type: COMPARATOR
Intervention: Information control (IC) targeting weight control only in the child.
Number of subjects: 105